Target Name: LOC107986454
NCBI ID: G107986454
Review Report on LOC107986454 Target / Biomarker Content of Review Report on LOC107986454 Target / Biomarker
LOC107986454
Other Name(s): Uncharacterized LOC107986454 | uncharacterized LOC107986454

LOC107986454: A Protein Targeted for Cancer and Neurodegenerative Diseases

LOC107986454 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the LOC10798645 gene family, which has been implicated in a number of cellular processes, including cell signaling, DNA replication, and metabolism.

Recent studies have identified LOC107986454 as a potential drug target, due to its involvement in a variety of cellular processes that are associated with various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. Additionally, LOC107986454 has been shown to interact with a number of different proteins, including tyrosine kinase, mitochondrial protein, and nuclear protein.

One of the key potential benefits of targeting LOC107986454 is its potential to modulate the activity of other proteins that are involved in the development and progression of various diseases. For example, LOC107986454 has been shown to play a role in the regulation of cell proliferation and survival, as well as in the development of neurodegenerative diseases. Additionally, LOC107986454 has been implicated in the regulation of metabolism and energy homeostasis, which are important factors in a variety of diseases, including obesity and diabetes.

Another potential mechanism by which LOC107986454 may be targeted as a drug is its role in the regulation of cellular signaling pathways. LOC107986454 has been shown to play a role in a variety of signaling pathways, including those that are involved in cell adhesion, migration, and survival. Additionally, LOC107986454 has been shown to interact with a number of different signaling proteins, including TGF-β1, FGF, and NF-kappa-B. Targeting LOC107986454 may therefore have the potential to modulate the activity of these signaling pathways and potentially improve the health outcomes of a variety of diseases.

In addition to its potential as a drug target, LOC107986454 also has potential as a biomarker for a variety of diseases. For example, LOC107986454 has been shown to be expressed in a variety of cancer types, including breast, ovarian, and colorectal cancer. Additionally, LOC107986454 has been shown to be involved in the regulation of cellular processes that are associated with the development and progression of these cancers, such as cell proliferation, apoptosis, and angiogenesis. As a result, LOC107986454 may have the potential to serve as a biomarker for cancer diagnosis, prognosis, and treatment.

Overall, LOC107986454 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Its involvement in a variety of cellular processes, including cell signaling, DNA replication, and metabolism, as well as its interaction with other proteins, makes it an attractive target for manipulation. Additionally, its potential as a biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and metabolic disorders, further enhances its potential as a research and clinical tool.

Protein Name: Uncharacterized LOC107986454

The "LOC107986454 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC107986454 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC107986469 | LOC107986517 | LOC107986522 | LOC107986528 | LOC107986537 | LOC107986544 | LOC107986545 | LOC107986561 | LOC107986589 | LOC107986594 | LOC107986595 | LOC107986597 | LOC107986598 | LOC107986606 | LOC107986613 | LOC107986622 | LOC107986623 | LOC107986626 | LOC107986636 | LOC107986649 | LOC107986666 | LOC107986764 | LOC107986766 | LOC107986770 | LOC107986771 | LOC107986772 | LOC107986774 | LOC107986776 | LOC107986777 | LOC107986781 | LOC107986787 | LOC107986800 | LOC107986816 | LOC107986820 | LOC107986836 | LOC107986844 | LOC107986873 | LOC107986892 | LOC107986894 | LOC107986901 | LOC107986903 | LOC107986927 | LOC107986930 | LOC107986952 | LOC107986961 | LOC107986983 | LOC107986996 | LOC107987026 | LOC107987045 | LOC107987049 | LOC107987053 | LOC107987057 | LOC107987064 | LOC107987087 | LOC107987099 | LOC107987121 | LOC107987164 | LOC107987178 | LOC107987211 | LOC107987243 | LOC107987249 | LOC107987251 | LOC107987282 | LOC107987285 | LOC107987299 | LOC107987301 | LOC107987304 | LOC107987407 | LOC107987412 | LOC107987429 | LOC107987435 | LOC107987440 | LOC107987443 | LOC107987449 | LOC107987453 | LOC107987459 | LOC112267867 | LOC112267881 | LOC112267902 | LOC112267956 | LOC112267962 | LOC112267968 | LOC112267978 | LOC112268051 | LOC112268136 | LOC112268248 | LOC112268286 | LOC112268294 | LOC112268416 | LOC114224 | LOC123862 | LOC124901339 | LOC126987 | LOC129026 | LOC132386 | LOC143666 | LOC145474 | LOC145845 | LOC148430 | LOC148696